Colony Sells the Buildings to Bury the Bond Losses
A $433M Georgia bank halves its loan growth guide, pushes its ROA target out to 3Q27, and pays for a securities cleanse with three branch sale-leasebacks.
CBAN · Earnings Call · 2026-10-29
The trade, finally priced in a number
For at least four consecutive quarters Heath Fountain has said some version of the same thing: Colony will not buy loan growth with margin. In January he drew the line plainly — “If we have to start doing things that are going to stop the margin improvement to result in higher growth, we just don't see that as the right trade-off.” — T. Fountain, CEO · 2026-01-29 In July he repeated it almost word for word. This quarter the philosophy finally got a number attached, and the number is roughly half the long-term target. “We think we'll be looking at loan growth around our current level of 5% for the coming year as we continue to prioritize improving profitability.” — Heath Fountain, CEO · 2026-10-29 That sits against a stated 8–12% range and a backward-looking brag that Colony has "averaged about 12% organic growth over the last eight years." Third-quarter growth was ~2% annualized, 5.4% year-to-date. So the guide is halved, explicitly, and dressed as discipline. The tell is the very next paragraph on ROA: “We still feel good about reaching our ROA target of 1.35% or better, but that will occur after we start to realize the full cost savings, which will begin in the third quarter of next year.” — Heath Fountain, CEO · 2026-10-29 They cleared a 1.25% operating ROA this quarter — and note the migrating goalpost. In July an analyst congratulated them on a "longer term 120 ROA goal"; today the target is 1.35%. The bar went up while the date went out, and management was candid that ROA gives back 10–15bp for several quarters running two core systems post-close. That's a four-quarter air pocket between the promise and the payoff, disclosed rather than buried — which is honest, and also hard to walk back later.Paying for a securities cleanse with branch real estate
The genuinely new item is the balance sheet restructure announced the same week as earnings: three retail branches sold and leased back on an initial 15-year term for $19.9M aggregate, $1.65M of first-year base rent escalating 2%, and a pre-tax gain of roughly $15M. Paired with the sale of about $100M of underperforming AFS securities yielding ~2%, with a 5.5% reinvestment assumption primarily into loans. The mechanics are the story:That is clean small-bank financial engineering. Crystallize AOCI marks the market already discounts, harvest a real-estate gain that never sat in AOCI, and let the two roughly cancel on the regulatory capital line while tangible book value rises — TBV per share to $15.16 from $15.12, TCE steady at 8.99% even after absorbing this quarter's marks. The cost is ~$1.8M of annual rent, under 1.5% of the combined expense base, against interest income from moving $100M out of 2% paper. Management is explicit it will not reinvest "back into similar duration bonds simply for the yield pickup" — the point is a shorter duration securities profile and a better interest rate risk profile, not a duration extension for yield's sake. The margin math behind it is the whole 2027 case. NIM improved 7bp to 3.59%; cost of funds ticked to 1.98% from 1.95%; new and renewed loan rates climbed to 7.26% from 7.14% — a third straight quarter of improvement off the 7.11% first-quarter trough, against a legacy portfolio yield around 6.35%. The repricing schedule is unusually concrete: $223M of fixed-rate loans at a 5.21% average and $76M of investments at 1.77% waiting to reprice into today's curve. Strip out purchase accounting and the core margin still grinds higher, which is why the lower growth guide doesn't panic anyone yet.The current tax adjusted unrealized losses on AFS securities are recorded in the AOCI, but the gain on the sale of the buildings is not, therefore will be accretive to tangible book value with neutral regulatory capital impacts.